Cesca Therapeutics Stock Price, News & Analysis (NASDAQ:KOOL)

$2.94 +0.09 (+3.16 %)
(As of 02/19/2018 04:00 PM ET)
Previous Close$2.85
Today's Range$2.80 - $3.02
52-Week Range$2.55 - $6.44
Volume74,100 shs
Average Volume107,979 shs
Market Capitalization$31.97 million
P/E Ratio-3.63
Dividend YieldN/A
Beta-1.05

About Cesca Therapeutics (NASDAQ:KOOL)

Cesca Therapeutics logoCesca Therapeutics Inc. is clinical-stage biotechnology company. The Company develops and markets integrated cellular therapies and delivery systems. The Company is engaged in developing and manufacturing of automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and tissue therapy products. The Company focuses on the business of research, development and commercialization of autologous cell-based therapeutics for use in the regenerative medicine industry. The Company's therapeutic development initiatives focuses on the fields of cardiovascular medicine and orthopedic regeneration. The Company offers a range of products, such as SurgWerks System, CellWerks System, AutoXpress System (AXP), MarrowXpress System (MXP), BioArchive System, and manual bag sets for use in the processing and cryogenic storage of cord blood.

Receive KOOL News and Ratings via Email

Sign-up to receive the latest news and ratings for KOOL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biopharmaceuticals
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:KOOL
CUSIPN/A
Phone916-858-5100

Debt

Debt-to-Equity Ratio0.16%
Current Ratio2.06%
Quick Ratio1.23%

Price-To-Earnings

Trailing P/E Ratio-3.62962962962963
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$14.52 million
Price / Sales2.20
Cash Flow$0.22 per share
Price / Cash13.66
Book Value$3.11 per share
Price / Book0.95

Profitability

Trailing EPS($0.81)
Net Income$-29,090,000.00
Net Margins-65.09%
Return on Equity-28.32%
Return on Assets-18.90%

Miscellaneous

Employees70
Outstanding Shares10,870,000

Cesca Therapeutics (NASDAQ:KOOL) Frequently Asked Questions

What is Cesca Therapeutics' stock symbol?

Cesca Therapeutics trades on the NASDAQ under the ticker symbol "KOOL."

How were Cesca Therapeutics' earnings last quarter?

Cesca Therapeutics Inc (NASDAQ:KOOL) announced its quarterly earnings results on Tuesday, February, 16th. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.05. The biotechnology company earned $3.29 million during the quarter, compared to analyst estimates of $4.32 million. Cesca Therapeutics had a negative net margin of 65.09% and a negative return on equity of 28.32%. View Cesca Therapeutics' Earnings History.

When will Cesca Therapeutics make its next earnings announcement?

Cesca Therapeutics is scheduled to release their next quarterly earnings announcement on Monday, February, 19th 2018. View Earnings Estimates for Cesca Therapeutics.

Who are some of Cesca Therapeutics' key competitors?

Who are Cesca Therapeutics' key executives?

Cesca Therapeutics' management team includes the folowing people:

  • Xiaochun Xu, Chairman of the Board, President, Chief Executive Officer (Age 45)
  • Jeffery Cauble, Principal Financial Officer, Principal Accounting Officer
  • Venkatesh Ponemone, Executive Director of India Operations, Director of Clinical and Scientific Affairs (Age 40)
  • Vivian Liu, Chief Operating Officer
  • Kimberly Ellner, Vice President of Manufacturing and Global Supply Chain (Age 49)
  • Russell M. Medford M.D., Ph.D., Director (Age 57)
  • Joseph Thomis, Director
  • James Xu, Director
  • Mahendra S. Rao Ph.D., Independent Director (Age 55)
  • Denis Michael Rhein, Independent Director (Age 56)

How do I buy Cesca Therapeutics stock?

Shares of Cesca Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cesca Therapeutics' stock price today?

One share of Cesca Therapeutics stock can currently be purchased for approximately $2.94.

How big of a company is Cesca Therapeutics?

Cesca Therapeutics has a market capitalization of $31.97 million and generates $14.52 million in revenue each year. The biotechnology company earns $-29,090,000.00 in net income (profit) each year or ($0.81) on an earnings per share basis. Cesca Therapeutics employs 70 workers across the globe.

How can I contact Cesca Therapeutics?

Cesca Therapeutics' mailing address is 2711 CITRUS ROAD, RANCHO CORDOVA CA, 95742. The biotechnology company can be reached via phone at 916-858-5100 or via email at [email protected]


MarketBeat Community Rating for Cesca Therapeutics (KOOL)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  89 (Vote Outperform)
Underperform Votes:  116 (Vote Underperform)
Total Votes:  205
MarketBeat's community ratings are surveys of what our community members think about Cesca Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cesca Therapeutics (NASDAQ:KOOL) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.002.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Cesca Therapeutics (NASDAQ:KOOL) Consensus Price Target History

Price Target History for Cesca Therapeutics (NASDAQ:KOOL)

Cesca Therapeutics (NASDAQ:KOOL) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/12/2017Maxim GroupReiterated RatingHoldLowView Rating Details
(Data available from 2/19/2016 forward)

Earnings

Cesca Therapeutics (NASDAQ:KOOL) Earnings History and Estimates Chart

Earnings by Quarter for Cesca Therapeutics (NASDAQ:KOOL)

Cesca Therapeutics (NASDAQ KOOL) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/19/2018        
11/14/2017Q1 2018($0.24)$3.07 millionViewN/AView Earnings Details
9/19/2017Q4 2017($0.01)$3.50 millionViewN/AView Earnings Details
5/11/2017Q3 2017($0.21)$3.25 millionViewN/AView Earnings Details
2/13/2017Q2 2017($0.35)$4.01 millionViewN/AView Earnings Details
11/17/2016Q1 2017($0.34)$3.77 millionViewN/AView Earnings Details
9/20/2016Q4 2016($1.01)$2.98 millionViewN/AView Earnings Details
5/13/2016Q3 2016($1.42)$2.83 millionViewN/AView Earnings Details
2/16/2016Q216($0.07)($0.02)$4.32 million$3.29 millionViewListenView Earnings Details
11/16/2015Q116($0.06)($0.08)$3.71 million$2.80 millionViewListenView Earnings Details
9/17/2015Q415($0.11)($0.06)$4.08 million$3.70 millionViewListenView Earnings Details
6/23/2015Q315($0.08)($0.12)$4.69 million$4.04 millionViewListenView Earnings Details
2/12/2015Q215($0.08)($0.11)$4.08 million$4.60 millionViewN/AView Earnings Details
11/13/2014Q115($0.08)$3.60 million$3.70 millionViewN/AView Earnings Details
9/29/2014Q4 2014($1.60)$3.84 millionViewN/AView Earnings Details
5/15/2014Q3 2014($0.05)($0.07)$4.04 millionViewN/AView Earnings Details
2/14/2014Q214($0.10)$4.80 million$4.50 millionViewN/AView Earnings Details
11/14/2013Q1($0.14)$3.64 millionViewListenView Earnings Details
8/29/2013Q4 2013($0.14)$4.50 million$4.10 millionViewN/AView Earnings Details
5/14/2013Q3 2013($1.40)$4.89 millionViewN/AView Earnings Details
2/12/2013Q2 2013($0.60)ViewN/AView Earnings Details
11/13/2012Q113$0.06$4.90 million$4.10 millionViewN/AView Earnings Details
9/20/2012Q4 2012($0.90)ViewN/AView Earnings Details
5/10/2012Q3 2012($2.14)ViewN/AView Earnings Details
2/9/2012Q2 2012($1.56)ViewN/AView Earnings Details
11/10/2011Q1 2012($1.48)ViewN/AView Earnings Details
9/12/2011Q4 2011($1.42)ViewN/AView Earnings Details
5/5/2011Q3 2011($1.14)ViewN/AView Earnings Details
2/10/2011Q2 2011$0.20($0.68)ViewN/AView Earnings Details
9/14/2010Q4 2010($0.80)($0.24)ViewN/AView Earnings Details
5/6/2010Q3 2010($1.92)ViewN/AView Earnings Details
2/4/2010Q2 2010($1.60)($2.08)ViewN/AView Earnings Details
11/5/2009Q1 2010($3.12)ViewN/AView Earnings Details
9/9/2009Q4 2009($0.80)($1.44)ViewN/AView Earnings Details
5/6/2009Q3 2009($1.60)($1.52)ViewN/AView Earnings Details
2/4/2009Q2 2009($3.20)($1.84)ViewN/AView Earnings Details
9/9/2008Q4 2008($2.40)($3.52)ViewN/AView Earnings Details
5/7/2008Q3 2008($1.60)($3.84)ViewN/AView Earnings Details
2/6/2008Q2 2008($2.48)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Cesca Therapeutics (NASDAQ:KOOL) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Cesca Therapeutics (NASDAQ:KOOL)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Cesca Therapeutics (NASDAQ KOOL) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 3.90%
Institutional Ownership Percentage: 2.79%
Insider Trades by Quarter for Cesca Therapeutics (NASDAQ:KOOL)
Insider Trades by Quarter for Cesca Therapeutics (NASDAQ:KOOL)

Cesca Therapeutics (NASDAQ KOOL) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/26/2016(Hong Kong) Ltd BoyalifeMajor ShareholderBuy6,102,942$2.52$15,379,413.846,838,237View SEC Filing  
11/10/2015Kenneth HarrisDirectorSell80,858$0.60$48,514.804,490,410View SEC Filing  
11/9/2015Kenneth HarrisDirectorSell48,468$0.60$29,080.804,490,410View SEC Filing  
11/6/2015Kenneth HarrisDirectorSell30,190$0.60$18,114.004,490,410View SEC Filing  
11/3/2015Kenneth HarrisDirectorSell10,510$0.60$6,306.004,571,268View SEC Filing  
11/2/2015Kenneth HarrisDirectorSell5,700$0.60$3,420.004,571,268View SEC Filing  
10/29/2015Kenneth HarrisDirectorSell8,632$0.60$5,179.204,581,778View SEC Filing  
9/2/2015Matthew T. PlavanCEOSell17,271$0.68$11,744.28245,066View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Cesca Therapeutics (NASDAQ KOOL) News Headlines

Source:
DateHeadline
Cesca Therapeutics Inc (NASDAQ:KOOL) And The Healthcare Industry Prospect For 2018Cesca Therapeutics Inc (NASDAQ:KOOL) And The Healthcare Industry Prospect For 2018
finance.yahoo.com - February 9 at 5:08 PM
Cesca Therapeutics Inc. to Present at the BIO CEO & Investor Conference on Monday, February 12, 2018Cesca Therapeutics Inc. to Present at the BIO CEO & Investor Conference on Monday, February 12, 2018
finance.yahoo.com - February 5 at 9:13 AM
Cesca Therapeutics (KOOL) versus Vitae Pharmaceuticals (VTAE) Critical SurveyCesca Therapeutics (KOOL) versus Vitae Pharmaceuticals (VTAE) Critical Survey
www.americanbankingnews.com - January 17 at 11:40 AM
Why Cesca Therapeutics Inc’s (NASDAQ:KOOL) Investor Composition Impacts Your ReturnsWhy Cesca Therapeutics Inc’s (NASDAQ:KOOL) Investor Composition Impacts Your Returns
finance.yahoo.com - January 8 at 4:43 PM
Cesca Therapeutics (KOOL) vs. Auxilium Pharmaceuticals (AUXL) Head to Head ReviewCesca Therapeutics (KOOL) vs. Auxilium Pharmaceuticals (AUXL) Head to Head Review
www.americanbankingnews.com - January 3 at 11:30 PM
Cesca Therapeutics Inc. to Present at Biotech Showcase on Tuesday, January 9, 2018Cesca Therapeutics Inc. to Present at Biotech Showcase on Tuesday, January 9, 2018
finance.yahoo.com - January 2 at 10:11 AM
Where Cesca Therapeutics Inc (NASDAQ:KOOL) Stands In Terms Of Earnings Growth Against Its IndustryWhere Cesca Therapeutics Inc (NASDAQ:KOOL) Stands In Terms Of Earnings Growth Against Its Industry
finance.yahoo.com - January 1 at 4:33 PM
Cesca Therapeutics, Inc. :KOOL-US: Earnings Analysis: Q1, 2018 By the Numbers : December 26, 2017Cesca Therapeutics, Inc. :KOOL-US: Earnings Analysis: Q1, 2018 By the Numbers : December 26, 2017
finance.yahoo.com - December 27 at 1:06 PM
ETFs with exposure to Cesca Therapeutics, Inc. : December 27, 2017ETFs with exposure to Cesca Therapeutics, Inc. : December 27, 2017
finance.yahoo.com - December 27 at 1:06 PM
Contrasting BioMarin Pharmaceutical (BMRN) & Cesca Therapeutics (KOOL)Contrasting BioMarin Pharmaceutical (BMRN) & Cesca Therapeutics (KOOL)
www.americanbankingnews.com - December 22 at 11:22 PM
Cesca Therapeutics (KOOL) vs. Fortress Biotech (FBIO) Head-To-Head ContrastCesca Therapeutics (KOOL) vs. Fortress Biotech (FBIO) Head-To-Head Contrast
www.americanbankingnews.com - December 22 at 9:20 PM
How Financially Strong Is Cesca Therapeutics Inc (KOOL)?How Financially Strong Is Cesca Therapeutics Inc (KOOL)?
finance.yahoo.com - December 7 at 4:54 PM
Zacks: Cesca Therapeutics Inc. (KOOL) Receives Average Rating of "Hold" from AnalystsZacks: Cesca Therapeutics Inc. (KOOL) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - December 3 at 5:38 AM
ETFs with exposure to Cesca Therapeutics, Inc. : December 1, 2017ETFs with exposure to Cesca Therapeutics, Inc. : December 1, 2017
finance.yahoo.com - December 1 at 5:36 PM
Cesca Therapeutics (KOOL) Plans Offering of Common StockCesca Therapeutics (KOOL) Plans Offering of Common Stock
www.streetinsider.com - November 30 at 4:34 PM
Cesca Therapeutics aims to raise nearly $3 million with share offeringCesca Therapeutics aims to raise nearly $3 million with share offering
www.bizjournals.com - November 30 at 10:57 AM
Cesca Therapeutics (KOOL) Prices 900K Common Stock Offering at $3/ShareCesca Therapeutics (KOOL) Prices 900K Common Stock Offering at $3/Share
www.streetinsider.com - November 29 at 10:23 AM
Cesca Therapeutics Inc. Announces Proposed Public Offering of Common StockCesca Therapeutics Inc. Announces Proposed Public Offering of Common Stock
finance.yahoo.com - November 29 at 10:23 AM
Cesca Therapeutics Inc. Announces Pricing of Public Offering of up to 900,000 shares of Common StockCesca Therapeutics Inc. Announces Pricing of Public Offering of up to 900,000 shares of Common Stock
finance.yahoo.com - November 29 at 10:23 AM
 Cesca Therapeutics Inc. (KOOL) Receives Consensus Rating of "Hold" from Brokerages Cesca Therapeutics Inc. (KOOL) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - November 28 at 11:16 AM
Cesca Therapeutics Announces Issuance of Second Cellular Processing PatentCesca Therapeutics Announces Issuance of Second Cellular Processing Patent
www.nasdaq.com - November 28 at 9:55 AM
Cesca Therapeutics Inc. (KOOL) Downgraded by ValuEngineCesca Therapeutics Inc. (KOOL) Downgraded by ValuEngine
www.americanbankingnews.com - November 15 at 10:22 PM
Cesca Therapeutics to Present at the Advanced Cell Therapy Shanghai Summit 2017Cesca Therapeutics to Present at the Advanced Cell Therapy Shanghai Summit 2017
finance.yahoo.com - November 15 at 3:52 AM
Cesca Therapeutics Inc. to Host Earnings CallCesca Therapeutics Inc. to Host Earnings Call
finance.yahoo.com - November 15 at 3:52 AM
Cesca Therapeutics Announces Financial Results for the Three Months Ended September 30, 2017 and Provides Corporate UpdateCesca Therapeutics Announces Financial Results for the Three Months Ended September 30, 2017 and Provides Corporate Update
finance.yahoo.com - November 15 at 3:52 AM
Cesca Therapeutics to Present at the Advanced Cell Therapy Shanghai Summit 2017Cesca Therapeutics to Present at the Advanced Cell Therapy Shanghai Summit 2017
feeds.benzinga.com - November 14 at 8:32 AM
Cesca Therapeutics to Announce Financial Results for the Three Months Ended September 30, 2017 and Host Conference Call on November 14thCesca Therapeutics to Announce Financial Results for the Three Months Ended September 30, 2017 and Host Conference Call on November 14th
finance.yahoo.com - November 8 at 12:51 PM
Cesca Therapeutics Inc. (KOOL) Set to Announce Quarterly Earnings on WednesdayCesca Therapeutics Inc. (KOOL) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - November 8 at 2:22 AM
ETFs with exposure to Cesca Therapeutics, Inc. : November 6, 2017ETFs with exposure to Cesca Therapeutics, Inc. : November 6, 2017
finance.yahoo.com - November 7 at 6:20 AM
ETFs with exposure to Cesca Therapeutics, Inc. : October 27, 2017ETFs with exposure to Cesca Therapeutics, Inc. : October 27, 2017
finance.yahoo.com - October 28 at 7:28 AM
Cesca Therapeutics (KOOL) versus Its Peers Critical SurveyCesca Therapeutics (KOOL) versus Its Peers Critical Survey
www.americanbankingnews.com - October 27 at 3:26 PM
ETFs with exposure to Cesca Therapeutics, Inc. : October 17, 2017ETFs with exposure to Cesca Therapeutics, Inc. : October 17, 2017
finance.yahoo.com - October 18 at 6:26 AM
Corporate News Blog - German Court Stays Infringement Proceedings Against Fisher & Paykel In ResMed Patent Infringement CaseCorporate News Blog - German Court Stays Infringement Proceedings Against Fisher & Paykel In ResMed Patent Infringement Case
finance.yahoo.com - October 9 at 4:20 PM
ETFs with exposure to Cesca Therapeutics, Inc. : October 6, 2017ETFs with exposure to Cesca Therapeutics, Inc. : October 6, 2017
finance.yahoo.com - October 7 at 1:40 AM
Cesca Therapeutics, Inc. :KOOL-US: Earnings Analysis: Q4, 2017 By the Numbers : October 4, 2017Cesca Therapeutics, Inc. :KOOL-US: Earnings Analysis: Q4, 2017 By the Numbers : October 4, 2017
finance.yahoo.com - October 5 at 7:26 AM
Patent Application Sends Cesca Therapeutics Shares SoaringPatent Application Sends Cesca Therapeutics Shares Soaring
feeds.benzinga.com - October 3 at 1:55 PM
Cesca Receives Notice of Allowance for U.S. Patent Application Covering a Novel Method of Cell SeparationCesca Receives Notice of Allowance for U.S. Patent Application Covering a Novel Method of Cell Separation
feeds.benzinga.com - October 3 at 8:05 AM
Contrasting Cesca Therapeutics (KOOL) and The CompetitionContrasting Cesca Therapeutics (KOOL) and The Competition
www.americanbankingnews.com - September 28 at 10:50 PM
Cesca Therapeutics to Present at Cell & Gene Therapy Bioprocessing & Commercialization 2017 - GlobeNewswire (press release)Cesca Therapeutics to Present at Cell & Gene Therapy Bioprocessing & Commercialization 2017 - GlobeNewswire (press release)
globenewswire.com - September 27 at 3:47 PM
Cesca Therapeutics to Present at the 2017 Cell & Gene Meeting on the Mesa - NasdaqCesca Therapeutics to Present at the 2017 Cell & Gene Meeting on the Mesa - Nasdaq
www.nasdaq.com - September 27 at 3:47 PM
Cesca Therapeutics to Present at the 2017 Cell & Gene Meeting on the MesaCesca Therapeutics to Present at the 2017 Cell & Gene Meeting on the Mesa
finance.yahoo.com - September 27 at 10:35 AM
ETFs with exposure to Cesca Therapeutics, Inc. : September 26, 2017ETFs with exposure to Cesca Therapeutics, Inc. : September 26, 2017
finance.yahoo.com - September 26 at 5:35 PM
Cesca Therapeutics, Inc. :KOOL-US: Earnings Analysis: 2017 By the Numbers : September 25, 2017Cesca Therapeutics, Inc. :KOOL-US: Earnings Analysis: 2017 By the Numbers : September 25, 2017
finance.yahoo.com - September 25 at 6:55 PM
Cesca Therapeutics to Present at Cell & Gene Therapy Bioprocessing & Commercialization 2017Cesca Therapeutics to Present at Cell & Gene Therapy Bioprocessing & Commercialization 2017
finance.yahoo.com - September 25 at 6:55 PM
Cesca Therapeutics Inc (KOOL) Files 10-K for the Fiscal Year Ended on June 30, 2017Cesca Therapeutics Inc (KOOL) Files 10-K for the Fiscal Year Ended on June 30, 2017
finance.yahoo.com - September 23 at 7:46 PM
Cesca Therapeutics Announces Fiscal Year 2017 Financial and Operating Results and Provides Corporate UpdateCesca Therapeutics Announces Fiscal Year 2017 Financial and Operating Results and Provides Corporate Update
finance.yahoo.com - September 20 at 12:14 AM
Cesca Therapeutics Inc. (KOOL) Announces Quarterly  Earnings ResultsCesca Therapeutics Inc. (KOOL) Announces Quarterly Earnings Results
www.americanbankingnews.com - September 19 at 8:38 PM
Cesca Therapeutics to Announce Fiscal Fourth Quarter and Full Year 2017 Financial Results and HostCesca Therapeutics to Announce Fiscal Fourth Quarter and Full Year 2017 Financial Results and Host
www.nasdaq.com - September 13 at 3:48 AM
Cesca Therapeutics to Announce Fiscal Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on September 19, 2017Cesca Therapeutics to Announce Fiscal Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on September 19, 2017
finance.yahoo.com - September 13 at 3:47 AM
Cesca Therapeutics Inc. (KOOL) to Release Earnings on MondayCesca Therapeutics Inc. (KOOL) to Release Earnings on Monday
www.americanbankingnews.com - September 11 at 1:28 AM

SEC Filings

Cesca Therapeutics (NASDAQ:KOOL) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Cesca Therapeutics (NASDAQ:KOOL) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Cesca Therapeutics (NASDAQ KOOL) Stock Chart for Monday, February, 19, 2018

Loading chart…

This page was last updated on 2/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.